Iovance Biotherapeutics Inc. Common Stock vs iShares US Aerospace & Defense ETF — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while iShares US Aerospace & Defense ETF trades at $206.65 (market cap $11.87B). The key difference: iShares US Aerospace & Defense ETF is the larger of the two by market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, iShares US Aerospace & Defense ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and iShares US Aerospace & Defense ETF for 19 Days on average.
| IOVA | ITA | |
|---|---|---|
Market Cap | $6.04B | $11.87B |
Volume | 14,805,993 | 1,060,125 |
Sector | Health | Sector/Thematic |
52-Week High | $14.82 | $253.22 |
52-Week Low | $1.81 | $198.23 |
Typical Hold Time | 0 Days | 19 Days |
Enterprise Value | $5.97B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →iShares U.S. Aerospace & Defense ETF seeks to track U.S. companies in the aerospace and defense sector. Its holdings include manufacturers of commercial and military aircraft, defense systems, and related equipment.
Read more on ITA →